药品专利保护与公共健康——对药品专利强制许可的重新审视  

Medicine Patent Protection and Public Health——Rethink of Medicine Patent Compulsory Licensing

作　　者：梁金马 Liang Jin-ma

机构地区：[1]南开大学法学院

出　　处：《科技与法律》2017年第3期39-46,共8页Science Technology and Law

摘　　要：强制许可可以在紧急情况下提升现有药物的可及性,但对药物进行专利保护激励对新药的研发却可以提升对潜在新药的可及性。这对经常被国际社会放在对立面的制度都促进公共健康水平的提高,应该协调一致。面对专利保护所导致的高价,应该选择对新药创新研发激励影响最小的方式来提升现有药物的可及性。Compulsory license can improve access to existing medicines in case of emergency, medical patent encourages research and development of new drugs, that is helpful to improve access to new drugs. This pair of contradiction both improve public health, they should cooperate each other. To improve access to existing drugs, the measure that discourage innovation of new drugs could not be chosen.

关 键 词：药品专利 公共健康 强制许可 

分 类 号：D923.4[政治法律—民商法学]